A preliminary analysis of consortium data for markers tightly linked to multiple endocrine neoplasia type 2A. 1992

J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
Department of Genetics, Yale University, New Haven, CT.

We have analyzed DNA marker typing data contributed by six independent groups to estimate the pairwise genetic distances between these markers and the locus for multiple endocrine neoplasia type 2A (MEN 2A). We used LIPED to calculate these distances for female, male, and sex-average linkage maps and to determine the corresponding LOD scores. The preliminary analyses of this large data set (89 MEN 2A families and five non-MEN 2A references families, with 1,934 total individuals) are reported here. These refined estimates of the genetic map in this region will aid in the assignment of presymptomatic diagnoses. This study clearly points out the limitation of pairwise linkage analysis in further refining the position of MEN2A in this small region of chromosome 10. Further refinement of the genetic map position of MEN2A will be best accomplished by finding, verifying, and accurately mapping crossovers in specific families.

UI MeSH Term Description Entries
D008126 Lod Score The total relative probability, expressed on a logarithmic scale, that a linkage relationship exists among selected loci. Lod is an acronym for "logarithmic odds." Lod Scores,Score, Lod,Scores, Lod
D008297 Male Males
D009377 Multiple Endocrine Neoplasia A group of autosomal dominant diseases characterized by the combined occurrence of tumors involving two or more ENDOCRINE GLANDS that secrete PEPTIDE HORMONES or AMINES. These neoplasias are often benign but can be malignant. They are classified by the endocrine glands involved and the degree of aggressiveness. The two major forms are MEN1 and MEN2 with gene mutations on CHROMOSOME 11 and CHROMOSOME 10, respectively. Adenomatosis, Familial Endocrine,Endocrine Neoplasia, Multiple,Multiple Endocrine Neoplasia Syndrome,Neoplasia, Multiple Endocrine,Neoplasms, Multiple Endocrine,Adenomatosis, Multiple Endocrine,Familial Endocrine Adenomatosis,Multiple Endocrine Adenomatosis,Multiple Endocrine Adenopathy,Multiple Endocrine Neoplasia Syndromes,Multiple Endocrine Neoplasms,Adenomatoses, Familial Endocrine,Adenomatoses, Multiple Endocrine,Adenopathies, Multiple Endocrine,Adenopathy, Multiple Endocrine,Endocrine Adenomatoses, Familial,Endocrine Adenomatoses, Multiple,Endocrine Adenomatosis, Familial,Endocrine Adenomatosis, Multiple,Endocrine Adenopathies, Multiple,Endocrine Adenopathy, Multiple,Endocrine Neoplasms, Multiple,Familial Endocrine Adenomatoses,Multiple Endocrine Adenomatoses,Multiple Endocrine Adenopathies
D002874 Chromosome Mapping Any method used for determining the location of and relative distances between genes on a chromosome. Gene Mapping,Linkage Mapping,Genome Mapping,Chromosome Mappings,Gene Mappings,Genome Mappings,Linkage Mappings,Mapping, Chromosome,Mapping, Gene,Mapping, Genome,Mapping, Linkage,Mappings, Chromosome,Mappings, Gene,Mappings, Genome,Mappings, Linkage
D002879 Chromosomes, Human, Pair 10 A specific pair of GROUP C CHROMOSOMES of the human chromosome classification. Chromosome 10
D005260 Female Females
D005819 Genetic Markers A phenotypically recognizable genetic trait which can be used to identify a genetic locus, a linkage group, or a recombination event. Chromosome Markers,DNA Markers,Markers, DNA,Markers, Genetic,Genetic Marker,Marker, Genetic,Chromosome Marker,DNA Marker,Marker, Chromosome,Marker, DNA,Markers, Chromosome
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
August 1989, Genomics,
J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
January 1993, Human genetics,
J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
December 1990, American journal of human genetics,
J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
April 1990, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
January 1991, Lancet (London, England),
J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
June 2012, The Kaohsiung journal of medical sciences,
J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
June 1992, Internal medicine (Tokyo, Japan),
J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
January 2006, Medicina (Kaunas, Lithuania),
J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
January 1988, Lancet (London, England),
J B Lichter, and S M Hackleman, and B A Ponder, and D Easton, and S A Narod, and G M Lenoir, and R F Gagel, and N E Simpson, and E Gardner, and P J Goodfellow
January 1987, Nature,
Copied contents to your clipboard!